Lidocaine Infusion in Hystroscopy

Ain Shams University

Status and phase: Completed; Phase 2

Conditions: Pain

Treatments: Drug: Lidocaine Hydrochloride; Drug: Diclofenac Sodium

Study type: Interventional

Funder types: Other

Identifiers

NCT03825016

AS1855

Details and patient eligibility

About

Lidocaine infusion in hystroscopic media versus oral diclofenac

Enrollment: 44 patients

Sex: Female

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 18-35 years
• BMI 18.5-30 kg/m2
• Diagnostic hystroscope

Exclusion criteria

• Previous cervical surgery
• Cervical stenosis
• PID
• allergy to NSAID
• Gastritis or peptic ulcer

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

44 participants in 2 patient groups

Lidocaine

Experimental group

Description:

Lidocaine Hydrochloride

Treatment:

Drug: Lidocaine Hydrochloride

Diclofenac

Experimental group

Description:

Oral Diclofenac

Treatment:

Drug: Diclofenac Sodium